Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Hexabrix
2. Ioxaglate
3. Ioxaglate Meglumine
4. Ioxaglate, Methylglucamine
5. Ioxaglic Acid
6. Ioxaglic Acid Monosodium Salt
7. Ioxaglic Acid, Calcium Salt (2:1)
8. Meglumine, Ioxaglate
9. Methylglucamine Ioxaglate
10. P-286 (contrast Media)
11. P286 (contrast Media)
1. Sodium Ioxaglate
2. 67992-58-9
3. Ioxaglate Sodium [usan]
4. Hq43cn02u9
5. Hexabrix
6. Ioxaglate Sodium (usan)
7. Sodium N-(2-hydroxyethyl)-2,4,6-triiodo-5-(2-(2,4,6-triiodo-3-(n-methylacetamido)-5-(methylcarbamoyl)benzamido)acetamido)isophthalamate
8. Sodium;3-[[2-[[3-[acetyl(methyl)amino]-2,4,6-triiodo-5-(methylcarbamoyl)benzoyl]amino]acetyl]amino]-5-(2-hydroxyethylcarbamoyl)-2,4,6-triiodobenzoate
9. Benzoic Acid, 3-((((3-(acetylmethylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)benzoyl)amino)acetyl)amino)-5-(((2-hydroxyethyl)amino)carbonyl)-2,4,6-triiodo-, Sodium Salt
10. Unii-hq43cn02u9
11. Einecs 268-060-2
12. Ioxaglic Acid Sodium
13. Schembl492669
14. Chembl1200743
15. Ioxaglate Sodium [vandf]
16. Dtxsid40218187
17. Sodium Ioxaglate [mart.]
18. Ioxaglate Sodium [who-dd]
19. Ioxaglate Sodium [orange Book]
20. Hexabrix Component Ioxaglate Sodium
21. Ft-0670407
22. Ioxaglate Sodium Component Of Hexabrix
23. D04599
24. Q27280055
25. Benzoic Acid, 3-((((3-(acetylmethylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)benzoyl)amino)acetyl)amino)-5-(((2-hydroxyethyl)amino)carbonyl)-2,4,6-triiodo-, Monosodium Salt
26. Sodium 3-((((3-(acetylmethylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)benzoyl)amino)acetyl)amino)-5-(((2-hydroxyethyl)amino)carbonyl)-2,4,6-triiodobenzoate
| Molecular Weight | 1290.9 g/mol |
|---|---|
| Molecular Formula | C24H20I6N5NaO8 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 10 |
| Exact Mass | 1290.5478 g/mol |
| Monoisotopic Mass | 1290.5478 g/mol |
| Topological Polar Surface Area | 197 Ų |
| Heavy Atom Count | 44 |
| Formal Charge | 0 |
| Complexity | 1100 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Contrast Media
Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)
ABOUT THIS PAGE
A Sodium Ioxaglate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium Ioxaglate, including repackagers and relabelers. The FDA regulates Sodium Ioxaglate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium Ioxaglate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sodium Ioxaglate supplier is an individual or a company that provides Sodium Ioxaglate active pharmaceutical ingredient (API) or Sodium Ioxaglate finished formulations upon request. The Sodium Ioxaglate suppliers may include Sodium Ioxaglate API manufacturers, exporters, distributors and traders.
Sodium Ioxaglate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium Ioxaglate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sodium Ioxaglate GMP manufacturer or Sodium Ioxaglate GMP API supplier for your needs.
A Sodium Ioxaglate CoA (Certificate of Analysis) is a formal document that attests to Sodium Ioxaglate's compliance with Sodium Ioxaglate specifications and serves as a tool for batch-level quality control.
Sodium Ioxaglate CoA mostly includes findings from lab analyses of a specific batch. For each Sodium Ioxaglate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium Ioxaglate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium Ioxaglate EP), Sodium Ioxaglate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium Ioxaglate USP).
LOOKING FOR A SUPPLIER?
